Brett Weathersby

Brett Weathersby is an experienced professional in the healthcare market, currently serving as the Director of Healthcare Market at Genentech since September 2024. Prior to this role, Brett held positions as Director of Key Accounts - East at Revance from January 2024 to September 2024, and as an Enterprise Account Executive at Definitive Healthcare from May 2022 to March 2023. Experience also includes serving as Key Account Director at Biogen, Division Sales Manager at Alder Biotherapeutics, and Regional Sales Manager - Rare Disease at CSL Behring. Brett's earlier career included roles such as Regional Manager at The Medicines Company and National Sales Trainer at Cubist Pharmaceuticals, with both companies later acquired by Novartis and Merck Pharmaceuticals, respectively. Brett is an alumnus of the University of Mississippi.